912330-17-7 Usage
Description
4,5,6,7-Tetrahydro-isoxazolo[4,5-c]pyridine-3-carboxylic acid, ethyl ester is a chemical compound that is a derivative of isoxazolo[4,5-c]pyridine. It is commonly used in pharmaceutical research and drug development due to its improved solubility and bioavailability in its ethyl ester form. Its structure and properties make it a promising candidate for further investigation in drug discovery and medicinal chemistry.
Used in Pharmaceutical Research and Drug Development:
4,5,6,7-Tetrahydro-isoxazolo[4,5-c]pyridine-3-carboxylic acid, ethyl ester is used as a research compound for the development of new drugs. Its ethyl ester form enhances its solubility and bioavailability, making it a promising candidate for drug discovery and medicinal chemistry.
Used in Central Nervous System Agents:
4,5,6,7-Tetrahydro-isoxazolo[4,5-c]pyridine-3-carboxylic acid, ethyl ester is used as a potential central nervous system agent for the treatment of neurological disorders and psychiatric conditions. Its structure and properties make it a promising candidate for further investigation in this area.
Used in Active Pharmaceutical Ingredients:
4,5,6,7-Tetrahydro-isoxazolo[4,5-c]pyridine-3-carboxylic acid, ethyl ester's ethyl ester form may further enhance its potential as an active pharmaceutical ingredient in future drug formulations. Its improved solubility and bioavailability make it a valuable compound for the development of new medications.
Check Digit Verification of cas no
The CAS Registry Mumber 912330-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,2,3,3 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 912330-17:
(8*9)+(7*1)+(6*2)+(5*3)+(4*3)+(3*0)+(2*1)+(1*7)=127
127 % 10 = 7
So 912330-17-7 is a valid CAS Registry Number.
912330-17-7Relevant articles and documents
BICYCLIC JAK INHIBITORS AND USES THEREOF
-
, (2020/10/20)
Provided herein are compounds of Formulas (I), (II), (III), and (IV) and subformulas thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), (II), (III), or (IV) and methods of using the compounds, e.g., in the treatment of immune disorders, inflammatory disorders, and cancer.
SUBSTITUTED SULFONAMIDE DERIVATIVES
-
, (2009/11/29)
The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.
